Home » Topics » Conferences

Conferences
RSS

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

July 28, 1998

Effects of RGH-2716 on neurotransmitter release and cerebral energy metabolism

July 28, 1998

AIT-082: a new neuroregenerative compound

July 28, 1998

Jenapharm describes scavestrogens, a novel class of nonfeminizing estrogens

July 23, 1998

Preclinical results point to anxiolytic efficacy for Yoshitomi benzodiazepine

July 22, 1998

Vigabatrin is effective for treating alcohol withdrawal syndrome

July 22, 1998

GV-150013 has dual therapeutic potential in treating alcoholism and sleep disorders

July 22, 1998

Analgesic effects of dosulepin in patients with cancer-related pain

July 22, 1998

Spotlight on sigma-receptors as a target for intervention in CNS disorders

July 22, 1998

New indication explored for established anticonvulsant

July 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.